Critical Path Institute Announces New CEO Critical Path Institute (C-Path) announced today that Dr. Carolyn Compton has joined the organization as its new president and chi
Critical Path Institute President and CEO Plans To Retire in 2012 Critical Path Institute’s Board of Directors today announced that President, CEO, and Chairman of the Board, Raymond L. Woos
Alfred M. Cohen, MD, FACS, FASCRS, Joins as Director, Cancer Biosignature Programs Alfred M. Cohen, MD, FACS, FASCRS, has joined Critical Path Institute (C-Path) as Director of its Cancer Biosignature Programs.
Martha Brumfield, PhD, Hired as Director, International Programs Martha Brumfield, PhD, has joined Critical Path Institute (C-Path) as Director of International Programs.
Leading Pharmacologist and Pharmaceutical Scientist Joins Critical Path Institute Thorir D. Bjornsson, MD, PhD, has joined Critical Path Institute as a member of its Board of Directors, and will also lead one of
Leading Neuroscientist Joins Critical Path Institute Marc Cantillon, MD, has joined Critical Path Institute as Executive Director of one of its major consortia, the Coalition Against
Raymond Woosley, MD, PhD, C-Path President/CEO to present keynote address at CDISC North American Exchange November 1-5, 2010 in Baltimore, MD The CDISC Board of Directors and Dr. Rebecca Kush, President & CEO are pleased to announce three exceptional keynote speakers
January 9, 2010 Pharmacometrics As A Discipline Is Entering The “Industrialization” Phase: Standards, Automation, Knowledge Sharing, And Training Are Critical For Future Success
Critical Path Institute President/CEO Receives Award of Excellence Raymond L. Woosley, MD, PhD, President/CEO of Tucson-based Critical Path Institute (CPI), was recently presented with the prestigi
Critical Path Institute Continues to Expand Stephen Joel Coons, PhD, Joins as Director of the newly formed Patient-Reported Outcomes Consortium
